These can manifest as skin rashes, itching, or respiratory symptoms
Current multi-society guidance indicates that most patients can continue GLP-1 receptor agonists before elective procedures
This hormone helps regulate blood sugar, slow digestion, reduce appetite, and improve insulin response
Indicated for patients targeting longevity, neurological performance, or recovery from metabolic decline
Many patients find that energy levels improve as their bodies adapt to the medication, though the timeline varies between individuals
When used with insulin or sulphonylureas: Consider dose reduction of these medications to reduce the risk of hypoglycaemia